CEO Andreas Bhagwani has privately and through his company Vega Bianca AB divested 323,000 shares in Nanologica AB for private economic reasons. At the same time, he exercised 227,566 options to shares. Following the transactions, Andreas Bhagwani’s holdings in Nanologica AB amounts to 2,019,764 shares, equivalent to 7.3 percent of the total number of shares in Nanologica, and 165,000 options.
“The sale is made for personal economic reasons. Nanologica remains my largest investment and commitment, and my strong confidence in the future for the company remains. I am 100 percent dedicated to Nanologica and to continue to lead and develop the company“, comments CEO Andreas Bhagwani.
The buyers of the shares consist of one institution and several private individuals, including board members of Nanologica (Mattias Bengtsson, Tomas Kramar and Anders Rabbe).
In connection with the transaction, Andreas Bhagwani has purchased a total of 82,566 options from members of the management team, which have since been exercised into shares together with Andreas Bhagwani’s previous holdings in the stock option program TO 2018/21.
For further information, please contact:
Johanna Johansson, IR Nanologica
Ph: +46 72 211 21 90 or e-mail: email@example.com
About Nanologica AB (publ)
Nanologica manufactures, develops, and sells nanoporous silica particles for applications within life science. Nanologica is world-leading in controlling the shape, size, porosity, and surface characteristics of silica particles. Through the two business areas, Drug Development and Chromatography, we strive towards reducing healthcare disparities throughout the world for the betterment of mankind. In Drug Development, we are committed to leverage our technology platform to solve medical problems in order to provide new treatments for patients with severe lung diseases. In Chromatography, we aim to make insulin available to more patients in need by reducing the production cost for manufacturers. Nanologica operates from the headquarters in Södertälje, Sweden and Nanologica’s stock (NICA) is listed on Spotlight Stock Market. For further information, please visit www.nanologica.com.